Seres Therapeutics, Inc. ($MCRB)
Filing Information
| Accession Number | 0001193125-26-057157 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 15, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
537
Total Value
$635.25
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial & Strategy Officer | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 231 | โ | โ | 8,632 | Direct | โ | View Details | |
EVP, Chief Commercial & Strategy Officer | Common Stock | โ | Feb 15, 2026 | Sale | 75 | $8.47 | $635.25 | 8,557 | Direct | โ | View Details | |
EVP, Chief Commercial & Strategy Officer | Restricted Stock Units | Derivative | Feb 15, 2026 | Exercise/Conversion | 133 | $0.00 | $0.00 | 531 | Direct | โ | View Details | |
EVP, Chief Commercial & Strategy Officer | Restricted Stock Units | Derivative | Feb 15, 2026 | Exercise/Conversion | 98 | $0.00 | $0.00 | 780 | Direct | โ | View Details |